Holocene Advisors
ONCS

Holocene Advisors’s OncoSec Medical Incorporated ONCS Stock Holding History

Holocene Advisors’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-30,588
Closed -$1.89M – 1020
2021
Q2 		$1.89M Buy
30,588
+1,385
+5% +$126K 0.01% 574
2021
Q1 		$3.06M Buy
+29,203
New +$4M 0.02% 494

Other funds holding ONCS

APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
SM
Salzhauer Michael $292M AUM 30% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Holocene Advisors's ONCS Position: Q3 2021 in Review

Holocene Advisors sold out of OncoSec Medical Incorporated (ONCS) in Q3 2021, closing a stake of 30,588 shares — an estimated $1.89M sold.

Holocene Advisors first reported a position in ONCS in Q1 2021 and held it in 2 quarters. The position peaked at $3.06M in Q1 2021. 31 funds tracked by Wall St. Rank hold ONCS as of Q3 2021.

  • Holocene Advisors reported no remaining OncoSec Medical Incorporated position as of Q3 2021 after selling out during the quarter.
  • Holocene Advisors sold 30,588 OncoSec Medical Incorporated shares in Q3 2021, an estimated $1.89M.
  • Holocene Advisors first reported a position in OncoSec Medical Incorporated in Q1 2021 and held it in 2 quarters.
  • Holocene Advisors's OncoSec Medical Incorporated position peaked at $3.06M in Q1 2021.
  • 31 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q3 2021.

Based on Holocene Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.